peptide-enzyme fusion with a modified version of the protein transduction domain (PTD) from the HIV-I transactivator of transcription (TAT) protein [2, 3] .
The transduction of TAT PTD across biological membranes is believed to primarily occur through the endocytic process of macropinocytosis [4, 5] . Demonstration of the PTD's ability to facilitate passage of fusion partners across membranes has resulted in investigation into TAT PTD-based therapies, such as for intracellular targeting of cancer cells [6] [7] [8] . Also, TAT PTD's capacity to transport intravenously-administered fusion molecules across the cell membrane and blood-brain barrier in mice may result in revolutionary treatments for focal ischemia after stroke [9] [10] [11] , mitochondrial disorders [12] , and lysosomal
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This report describes a cellulose affinity method for purification of the Naglu-TAT PTD fusion enzyme (modTATlNaglu) for potential enzyme replacement therapy. The construct, which was produced via secretory expression from Spodoptera frugiperda 9 (Sf9) cells, contained an N-terminal cellulose binding domain (CBD) from the Cellulomonas fimi exoglucanase Cex [15] , followed by the Ile-Glu-Gly-Arg Factor Xa recognition sequence for subsequent seamless excision of the affinity tag. Cellulose affinity purification is an attractive purification method due to the low cost substrate and high specificity of the CBD for cellulose [16] . The described cellulose affinity protocol resulted in a 382-fold purification of active modTATlNaglu with a yield of 18% from concentrated Sf9 culture medium.
Materials and methods
Sf9 cultures with the stably integrated modTATlNaglu expression plasmid ( Figure 1 ) were prepared as described previously from our laboratory [2] . Large scale cultures were seeded and harvested according to the protocol of Vaags [17] . Crude medium was concentrated 15-fold using an Amicon 8200 Stirred Ultrafiltration Cell (Millipore, Billerica, MA) at 25 psi pressure, 4 o C with a 10,000 NMWL polyethersulfone membrane. Concentrated medium was then adjusted to 1 M NaCl, 0.3% Triton X-100, pH 9.0. After incubation on ice with gentle shaking for 1 h, the medium was centrifuged at 15,000 x g for 5 min. to remove precipitate. One mL of medium was added to 15 mg of Sigmacell Cellulose Type 101 (Sigma-Aldrich Canada, Oakville, ON) equilibrated with wash buffer (50 mM TrisHCl, 1 M NaCl, 0.3% Triton X-100, pH 9.0) and incubated for 2 hrs on ice with vigorous shaking. The cellulose pellet was then washed with wash buffer, distilled water, and 1X Factor Xa Cleavage/Capture Buffer (EMD Biosciences, San Diego, CA). To prepare for Factor Xa digestion, the bulk of Factor Xa Cleavage/Capture Buffer was removed, and the cellulose was resuspended in the remaining buffer to form a thick slurry. Twelve units of Novagen Factor Xa (EMD Biosciences, San Diego, CA) were added to the slurry and incubated for 18-20 hrs at 37 o C with vigorous shaking. Protein was then eluted from the cellulose in 100 µL increments and fractions with the highest Naglu activity were pooled (~first three). Factor Xa removal was performed using Xarrest Agarose (EMD Biosciences, San Diego, CA) according to the manufacturer's instructions. All centrifugation steps were performed in a microcentrifuge at 15,000 x g for two min.
Naglu activity was measured using the 4-methylumbelliferyl-N-acetyl-α-D-glucosaminide fluorogenic substrate according to the protocol of Zhao and Neufeld [18] . Purity of samples was assessed using sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) followed by protein staining using silver dye [19] . Protein concentrations were measured with the Bio-Rad Protein Assay kit (Bio-Rad, Hercules, CA) using bovine serum albumin as standard.
Results and discussion
Use of the Cellulomonas fimi Cex CBD allowed simple and efficient purification of active modTATlNaglu enzyme that appears as a major protein band of ~80 kD (the expected size) upon SDS-PAGE and protein staining using silver dye (Figure 2, lane 3) . The enzyme was purified 382-fold with a yield of 18% from concentrated Sf9 medium (Table 1) . Yield from unconcentrated medium was closer to 13%, as 
use of the Amicon apparatus under described conditions typically resulted in 70% retention of modTATlNaglu (data not shown). Attempts to concentrate modTATlNaglu secreted in culture medium using ammonium sulfate precipitation was unsatisfactory, as ammonium sulfate apparently reacted with ingredient(s) in the SF900 medium that formed a colloidal-like buoyant substance, trapping and thus preventing modTATlNaglu from recovery using centrifugation, even at 50,000 x g for more than one hr.
Binding specificity of Sigmacell Type 101 cellulose varied dramatically based on the condition of crude medium. Several conditions were tested, and binding specificity was assessed visually through direct denaturation of bound proteins from cellulose followed by SDS-PAGE and staining with silver dye. Binding with unaltered, concentrated medium provided little purification, since SDS-PAGE and silver dye staining of eluted Naglu showed that the protein bands were similar to that of the crude, unpurifed enzyme ( Figure 2 , lane 2), while alteration of medium to 0.1% Triton X-100, pH 8.5 provided a reduction in nonspecific binding [2] . Increasing the ionic strength of crude medium resulted in a significant improvement, with the highest binding specificity achieved through alteration of medium to 1 M NaCl, 0.3% Triton X-100, pH 9.0. The on-cellulose Factor Xa digest to release modTATlNaglu provided additional purification, as strongly absorbed contaminating proteins were removed with the cellulose pellet. It is of interest to note that while some CBD-fusion proteins can easily be eluted from cellulose using water [20] , this is not the case for modTATlNaglu as its affinity binding to cellulose is very strong and requires proteolytic cleavage using Factor Xa for recovery from the cellulose resins.
The specific activity of Naglu purified from CHO (Chinese hamster ovary) cells reported by Zhao and Neufeld at 30,000 units per mg protein [18] is higher than that of modTATlNaglu as reported in this communication. This may be attributable to the difference in amino acid sequence between Naglu and modTATlNaglu, the later being a chimeric enzyme fused with the eleven amino acid HIV-Tat protein transduction domain, as well as the difference between CHO and Sf9 cell expression systems. Naglu is a lysosomal hydrolase with an optimal pH for activity of 4.5 [21] . Although the described protocol required a large increase in culture medium pH, there was no apparent loss of Naglu activity, as activity was restored upon returning crude medium to its original pH of around 5.8 (data not shown). To best preserve Naglu activity, most protocol steps were performed at refrigerating temperatures or on ice. Naglu, however, has been shown to remain stable at high temperatures, with the purified enzyme withstanding incubation for one hr at 50 o C without significant loss of activity [21] . Though some Naglu may have been inactivated during the prolonged 37 o C Factor Xa cleavage step, this condition resulted in optimal retrieval of active modTATlNaglu.
Conclusion
We have expressed human recombinant Naglu as a catalytically active fusion enzyme with the eleven amino acid HIV-Tat protein transduction domain and a cellulosebinding affinity domain in cultured Sf9 cells. The recombinant enzyme secreted in the culture medium was adsorbed onto cellulose resins (Sigmacell Type 101) and purified 382-fold with 18% overall yield upon washing, recovery using Factor Xa digestion, and removal of the affinity tag using Xarrest Agarose (EMD Biosciences). The described protocol provides an effective cellulose affinity method for purification of Naglu. In addition, the low cost, availability, high binding specificity of cellulose under defined experimental conditions, and relative simplicity of this one-step affinity purification method will permit scaled-up enzyme production for transport and uptake studies for potential enzyme replacement therapy.
